Crossref
TCT-76 Less Than 6 Versus 6 Months or Longer of Dual Antiplatelet Therapy After Successful CTO-PCI
JACC · 2026-11 · 88 (18) · B31
DOI: 10.1016/j.jacc.2026.09.126 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-11. Verfasst von Junghoon Lee und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lee, J., Choi, Y., Kwon, O., Rha, S., Kim, B., Cho, J. R., Han, J., Hwang, B., Kim, U., Kook, H., Lee, S., Suh, J., & Yoon, C. (2026). TCT-76 Less Than 6 Versus 6 Months or Longer of Dual Antiplatelet Therapy After Successful CTO-PCI. JACC, 88(18), B31. https://doi.org/10.1016/j.jacc.2026.09.126
Vancouver
Lee J, Choi Y, Kwon O, Rha S, Kim B, Cho JR, et al. TCT-76 Less Than 6 Versus 6 Months or Longer of Dual Antiplatelet Therapy After Successful CTO-PCI. JACC. 2026;88(18):B31. doi:10.1016/j.jacc.2026.09.126
BibTeX
@article{Lee2026,
author = {Lee, Junghoon and Choi, Yeon-Jik and Kwon, Osung and Rha, Seung-Woon and Kim, Byeong-Keuk and Cho, Jung Rae and Han, Jung-Kyu and Hwang, Byung-Hee and Kim, Ung and Kook, Hyungdon and Lee, Seung-Whan and Suh, Jon and Yoon, Chang-Hwan},
title = {TCT-76 Less Than 6 Versus 6 Months or Longer of Dual Antiplatelet Therapy After Successful CTO-PCI},
journal = {JACC},
year = {2026},
volume = {88},
number = {18},
pages = {B31},
doi = {10.1016/j.jacc.2026.09.126}
}
EUVIMED